MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals
Authors
Keywords
Pituitary adenoma, MGMT, Time dependent, Promoter methylation
Journal
Pituitary
Volume 21, Issue 3, Pages 266-273
Publisher
Springer Nature
Online
2018-01-17
DOI
10.1007/s11102-018-0862-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas
- (2017) Alexander S. G. Micko et al. Pituitary
- Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
- (2015) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Non-uniform Response to Temozolomide Therapy in a Pituitary Gonadotroph Adenoma
- (2014) Ayca Ersen et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Aggressive silent corticotroph adenoma progressing to pituitary carcinoma. The role of temozolomide therapy
- (2014) Olga Moshkin et al. Hormones-International Journal of Endocrinology and Metabolism
- MGMT promoter methylation in non-neoplastic brain
- (2014) Chih-Yi Hsu et al. JOURNAL OF NEURO-ONCOLOGY
- Aggressive Silent GH Pituitary Tumor Resistant to Multiple Treatments, Including Temozolomide
- (2013) Marie Batisse et al. CANCER INVESTIGATION
- Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma
- (2013) Matthias Preusser et al. CLINICAL NEUROPATHOLOGY
- DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
- (2013) Toshio Hirohata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide in the management of dopamine agonist-resistant prolactinomas
- (2012) B. C. Whitelaw et al. CLINICAL ENDOCRINOLOGY
- Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment
- (2012) Gérald Raverot et al. CLINICAL ENDOCRINOLOGY
- MGMT expression and pituitary tumours: relationship to tumour biology
- (2012) Ann McCormack et al. Pituitary
- Correlation between quantified promoter methylation and enzymatic activity of O 6-methylguanine-DNA methyltransferase in glioblastomas
- (2012) Yugo Kishida et al. TUMOR BIOLOGY
- Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
- (2011) Ann I. McCormack et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
- (2011) Jörg Felsberg et al. INTERNATIONAL JOURNAL OF CANCER
- Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
- (2011) Guido Reifenberger et al. INTERNATIONAL JOURNAL OF CANCER
- MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas
- (2011) Fateme Salehi et al. JOURNAL OF NEURO-ONCOLOGY
- A Mechanism of Acquiring Temozolomide Resistance During Transformation of Atypical Prolactinoma Into Prolactin-Producing Pituitary Carcinoma: Case Report
- (2011) Mineko Murakami et al. NEUROSURGERY
- O-6-Methylguanine-DNA Methyltransferase (MGMT) Immunohistochemical Expression in Pituitary Corticotroph Adenomas
- (2011) Fateme Salehi et al. NEUROSURGERY
- Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature
- (2011) A. K. Annamalai et al. Pituitary
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- Temozolomide-Induced Shrinkage of a Pituitary Carcinoma Causing Cushing's Disease — Report of a Case and Literature Review
- (2011) Lorenzo Curtò et al. TheScientificWorldJOURNAL
- Treatment of pituitary neoplasms with temozolomide
- (2010) Luis V. Syro et al. CANCER
- Dose-dense temozolomide regimens
- (2010) Bart Neyns et al. CANCER
- MGMT Immunoexpression in Silent Subtype 3 Pituitary Adenomas: Possible Therapeutic Implications
- (2010) Michael E. Fealey et al. ENDOCRINE PATHOLOGY
- Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
- (2010) Marco Losa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Proteomic analysis of RCL2 paraffin-embedded tissues
- (2010) V. Bellet et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
- (2010) Zachary M. Bush et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MGMT immunoexpression in aggressive pituitary adenoma and carcinoma
- (2010) Queenie Lau et al. Pituitary
- Careful Exclusion of Non-neoplastic Brain Components is Required for an Appropriate Evaluation of O6-methylguanine-DNA Methyltransferase Status in Glioma
- (2009) Ken Sasai et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- O6-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas
- (2009) Georg Widhalm et al. CANCER
- Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma
- (2009) C. K. Augustine et al. CLINICAL CANCER RESEARCH
- High incidence of low O6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease
- (2009) Akira Takeshita et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
- (2009) C Hagen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMAS
- (2009) Van Thang Cao et al. NEUROSURGERY
- USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS
- (2009) Safraz Mohammed et al. NEUROSURGERY
- Anti-O6-Methylguanine-Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker
- (2008) Matthias Preusser et al. BRAIN PATHOLOGY
- Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
- (2008) Ann I. McCormack et al. CLINICAL ENDOCRINOLOGY
- Treatment of Nelson's syndrome with temozolomide
- (2008) V J Moyes et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started